Daniel Auclair, President of Hematocure, shared a post on X:
“1. ASH25 LBCL
Dual CD19/CD20: Kite-363 Dr. Saurabh Dahiya, Dr. Sairah Ahmed
Read the full article.
Ronde-cel Dr. Sarah Larson, Dr. Akil Merchant
Read the full article.
Zamto-cel Dr. Peter Borchmann, Dr. Nirav Shah
Read the full article.
2. ASH25 new agents for LBCL
CelMod Golcadomide: Dr. Grzegorz Nowakowski, Dr. Jason Westin
Read the full article.
Dr. Marc Hoffmann, Dr. Jason Westin, Dr. J M Michot
Read the full article.
Bcl-6 degrader BMS-986458: Dr. Franck Morschhauser, Dr. J M Michot
Read the full article.”
More posts featuring Daniel Auclair.